Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
News
Outbreaks
Vaccines
Herpes Simplex 2
Fact checked by
Kelley Lu, PharmD
Jul 29
5 min read
Herpes Vaccine Candidate Delta gD-2 Accelerates With $56 Million Dollars
X-Vax Technology Delta gD-2 (∆gD-2) herpes vaccine candidate
Herpes
Herpesvirus
Herpes Simplex 1
Herpes Simplex 2
Fact checked by
Robert Carlson, MD
Jun 15
8 min read
Why Did Herpes Vaccines Stall in Phase 2 Study?
Herpes simplex virus 2 HSV2 vaccines may benefit from a prime and pull approach
Herpes
Herpesvirus
Herpes Simplex 1
Herpes Simplex 2
Fact checked by
Robert Carlson, MD
May 30
3 min read
Herpes Vaccine Candidate HSV529 Reports Positive Phase 1 Results
Sanofi Replication-Defective Herpes Simplex Virus 2 Vaccine HSV529 was safe and elicited neutralizing antibody and modest CD4+ T-cell responses in HSV seronegative vaccinees
Herpes
Herpesvirus
Herpes Simplex 1
Herpes Simplex 2
Fact checked by
Robert Carlson, MD
May 29
5 min read
Herpes Vaccines Need Help
Herpes HSV-1 and HSV-2 continue to recombine and frustrate vaccine candidates
Herpes
Herpesvirus
Herpes Simplex 1
Herpes Simplex 2
Sexually Transmitted Diseases
Fact checked by
Robert Carlson, MD
Apr 17
6 min read
Neonatal Herpes Acquired From Mom Can Be Fatal
Neonatal herpes virus (nHSV) infections in infants can be treated with Acyclovir up to 3 months of age
Herpes
Herpesvirus
Herpes Simplex 1
Herpes Simplex 2
Show more